Tunisian Pharmaceutical Industries Company (Siphat) Resumes Operations with a Focus on Intravenous Solution Production
The Tunisian Pharmaceutical Industries Company (Siphat) has resumed operations in most of its units, with a particular emphasis on the production of intravenous solutions in sachets. The goal is to ensure the supply of essential medicines and improve the country's pharmaceutical security.
It is worth noting that, according to an official statement published on September 18, Siphat will increase its production, particularly by doubling the volume of injectable solutions.
The company also plans to resume the manufacture of medicines and medical equipment, while strengthening digitalization and quality control measures.
The Minister of Health highlighted in the same statement the importance of effective human resource management and the fight against corruption to ensure transparency and performance within the company.
With its numerous production units, Siphat is committed to respecting strict quality standards at all stages, from manufacturing to storage, to guarantee a reliable supply of medicines to the national market.
